Clinical trial
Clinical Study Evaluating the Possible Efficacy and Safety of Roflumilast in Patients With Diabetic Nephropathy
NCT04755946 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study Evaluating the Possible Efficacy and Safety of Roflumilast in Patients With Diabetic Nephropathy
- Lead sponsor
- Tanta University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- March 10, 2021
- Completion date
- July 10, 2021
- Enrollment
- 48 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.